Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-04 Sale |
2020-12-08 4:01 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
5,639 | $12.5 | $70,488 | 93,041 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 4:02 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
3,561 | $11.75 | $41,842 | 93,041 (Direct) |
View |
| 2020-11-06 Sale |
2020-11-10 4:10 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
2,797 | $11.14 | $31,161 | 93,041 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 4:03 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
22,714 | $10.5 | $238,497 | 95,838 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 4:01 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
575 | $10.14 | $5,831 | 118,552 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-13 5:20 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
1,153 | $10.35 | $11,934 | 118,147 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Exercise |
2025-02-20 7:29 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
15,477 | $0 | 60,180 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-20 7:29 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
4,975 | $12.93 | 60,180 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 5:10 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
16,000 | $0 | 147,149 (Direct) |
View |
| 2025-02-13 Tax Withholding |
2025-02-18 5:10 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
5,318 | $12.69 | 147,149 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 5:10 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
128,424 | $0 | 147,149 (Direct) |
View |
| 2025-02-10 Exercise |
2025-02-12 4:59 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
5,333 | $0 | 8,043 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:59 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
1,997 | $13.2 | 8,043 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:44 pm |
N/A 2031-02-15 |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
111,430 | $0 | 111,430 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 5:16 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
5,333 | $0 | 10,040 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-13 5:16 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
2,985 | $12.82 | 10,040 (Direct) |
View |
| 2023-02-27 Exercise |
2023-03-01 4:52 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
5,334 | $0 | 13,025 (Direct) |
View |
| 2023-02-27 Tax Withholding |
2023-03-01 4:52 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
2,975 | $10.36 | 13,025 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:25 pm |
N/A 2030-02-15 |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:09 pm |
N/A 2029-02-09 |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
106,500 | $0 | 106,500 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-02 7:58 pm |
N/A 2028-02-29 |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
350,000 | $0 | 350,000 (Direct) |
View |
Ownership |
2021-03-02 7:55 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO |
0 | $0 | 0 (Direct) |
View |
| 2020-12-04 Exercise |
2020-12-08 4:01 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
5,639 | $9.12 | 93,041 (Direct) |
View |
| 2020-12-04 Exercise |
2020-12-08 4:01 pm |
N/A 2026-03-01 |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
5,639 | $0 | 93,041 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 4:02 pm |
N/A 2025-10-01 |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
3,561 | $0 | 93,041 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 4:02 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer |
3,561 | $9.31 | 93,041 (Direct) |
View |